A federal appeals court late Friday blocked the ability of doctors to prescribe the abortion pill mifepristone through telehealth and dispensed through the mail. A three-judge panel on the 5th U.S. Circuit Court of Appeals sided with Louisiana in a lawsuit against the Food and Drug Administration (FDA). The court issued a temporary nationwide injunction that reinstates a 2021 nationwide requirement that mifepristone must be prescribed and dispensed in person. Mifepristone is one of the two drugs commonly used in medication abortions. The FDA permanently lifted the in-person requirement in 2023, leading to a surge in pills prescribed over the internet in the wake of the Dobbs ruling that overturned the constitutional right to an abortion. Louisiana argued the FDA rules made it easier for abortion pills to be mailed into states where abortion is banned. The appeals court said Louisiana showed it was likely to succeed in its challenge and was suffering irreparable harm.…